Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 80 pages
Exam (elaborations)

GEORGETTE'S LMR PMHNP CERTIFICATION REVIEW: ORIGINAL EXAM SET : 150 VERIFIED QUESTIONS WITH DETAILED /UPDATED RATIONALES

Document preview thumbnail
Preview 4 out of 80 pages

GEORGETTE'S LMR PMHNP CERTIFICATION REVIEW: ORIGINAL EXAM SET : 150 VERIFIED QUESTIONS WITH DETAILED /UPDATED RATIONALES Nursing / Neurobiology, Psychopharmacology, Neurotransmitter / Psychotherapy Exam summary : • Section A (Q1-33): Scientific Foundation – Covers neurobiology, psychopharmacology, neurotransmitter systems, and medication mechanisms. • Section B (Q34-74): Advanced Practice Skills – Focuses on clinical interviewing, screening tools, mental status exam, risk assessment, and differential diagnosis. • Section C (Q75-107): Diagnosis and Treatment – Covers DSM 5 criteria, medication selection, treatment planning, and management strategies. • Section D (Q108-124): Psychotherapy and Related Theories – Addresses CBT, DBT, IPT, psychodynamic therapy, and therapeutic modalities. Page 2 of 80 • Section E (Q125-150): Ethics, Legal Principles, and Cultural Care – Covers informed consent, confidentiality, duty to warn, involuntary commitment, scope of practice, and cultural competence.

Content preview

Page 1 of 80


GEORGETTE'S LMR PMHNP CERTIFICATION REVIEW:
ORIGINAL EXAM SET : 150 VERIFIED QUESTIONS WITH
DETAILED /UPDATED RATIONALES


Nursing / Neurobiology, Psychopharmacology, Neurotransmitter / Psychotherapy



Exam summary :
• Section A (Q1-33): Scientific Foundation – Covers
neurobiology, psychopharmacology, neurotransmitter
systems, and medication mechanisms.


• Section B (Q34-74): Advanced Practice Skills – Focuses on
clinical interviewing, screening tools, mental status exam,
risk assessment, and differential diagnosis.


• Section C (Q75-107): Diagnosis and Treatment – Covers DSM-
5 criteria, medication selection, treatment planning, and
management strategies.


• Section D (Q108-124): Psychotherapy and Related Theories –
Addresses CBT, DBT, IPT, psychodynamic therapy, and
therapeutic modalities.

, Page 2 of 80


• Section E (Q125-150): Ethics, Legal Principles, and Cultural
Care – Covers informed consent, confidentiality, duty to warn,
involuntary commitment, scope of practice, and cultural
competence.


SECTION A: SCIENTIFIC FOUNDATION (Questions 1-33)
1. A patient with schizophrenia has been non-adherent with
antipsychotic medication due to extrapyramidal symptoms.
Which neurotransmitter pathway is primarily responsible for
these side effects?
A. Mesolimbic pathway
B. Nigrostriatal pathway ✓
C. Mesocortical pathway
D. Tuberoinfundibular pathway


CORRECT: B
RATIONALE: The nigrostriatal dopamine pathway is responsible
for motor control; blockade here causes EPS. The mesolimbic
pathway is associated with positive symptoms, and the
tuberoinfundibular pathway is associated with prolactin
elevation.

, Page 3 of 80


2. A PMHNP is reviewing the mechanism of action of SSRIs.
Which of the following best describes the primary effect of
these medications?
A. Inhibition of norepinephrine reuptake
B. Selective inhibition of serotonin reuptake at the presynaptic
neuron ✓
C. Inhibition of monoamine oxidase
D. Antagonism of dopamine D2 receptors


CORRECT: B
RATIONALE: SSRIs selectively block serotonin reuptake,
increasing serotonin availability in the synaptic cleft. SNRIs
affect both serotonin and norepinephrine.


3. A patient with bipolar disorder is prescribed lithium. Which of
the following is the most serious potential side effect that
requires monitoring?
A. Weight gain
B. Nephrogenic diabetes insipidus and thyroid dysfunction ✓
C. Sexual dysfunction
D. Insomnia

, Page 4 of 80


CORRECT: B
RATIONALE: Lithium can cause nephrogenic diabetes insipidus
and hypothyroidism; monitoring renal and thyroid function is
essential. Weight gain and sexual dysfunction are also side
effects but not as serious.


4. A patient presents with symptoms of major depressive
disorder. The PMHNP understands that which neurotransmitter
is most directly involved in the pathophysiology of depression?
A. Acetylcholine
B. Serotonin ✓
C. GABA
D. Histamine


CORRECT: B
RATIONALE: Serotonin is the primary neurotransmitter
implicated in depression. GABA is associated with anxiety
disorders. Acetylcholine and histamine are less directly
involved.


5. Which of the following best describes the mechanism of
action of benzodiazepines?

Document information

Uploaded on
August 13, 2026
Number of pages
80
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$23.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
55
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions